Anti-Cancer Medicine

Xovoltib 20mg Xovoltib 20mg  is indicated for the first-line treatment for patients with metastatic non-small cell lung cancer(NSCLC). DESCRIPTION : Xovoltib 20mg is a type of regimen called protein kinase inhibitors. Xovoltib 20mg is a targeted therapy drug It used to treat non-small cell lung cancer (NSCLC). It may also be used to treat other cancers as part of clinical trial. Xovoltib 20mg is a prescription drugs which is used under the supervision of medical practioners. MECHANISM OF ACTION : Xovoltib 20mg stops the activating sites called tyrosine kinases of various proteins within the cell. These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. By stopping these targets, it will target the cancer will shrink. DOSAGE AND ADMINISTRATION : Take Xovoltib on an empty stomach. Consume the drug 1 hour before or 2 hours after a meal Avoid cutting or crushing the tablet. For adult : The usual dose for metastatic non-smal...

ALECENSA 150MG Description : Alecensa is a prescription drug which used under the guidance of doctor. It is part used in the treatment of non-small cell lung cancer (NSCLC) expressing the ALK-EML4 (echinoderm microtubule-associated protein-like 4) fusion protein that causes proliferation of NSCLC cells. Alecensa 150mg belongs to class of second generation oral drug which specificallyprevents the activity of anaplastic lymphoma kinase (ALK) tyrosine kinase. Indication : Alecensa 150mg is used for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). ADME Peak plasma concentration 4 hours and bioavailability of Alecensa 37% Alectinib bound to human plasma proteins 99% Metabolized by CYP3A4 to its major active metabolite M4, the main circulating moieties in plasma, total radioactivity 76% constituting. In oral administration, radioactivity 98% was excreted in feces. 84% dose was excreted in the feces unchanged ...

SCAPHO 150MG Description Scapho 150mg belongs to immuno suppressant which decrease the effects of a chemical substance in the body which can cause inflammation. Scapho 150mg is required to treat moderate to severe plaque psoriasis (raised, silvery flaking of the skin) in adults. Indication Scapho indicated for the treatment of following condition : Plaque Psoriasis Psoriatic arthritis Ankylosing spondylitis. ADME Absorption: peak plasma concentration for single dose is 6 days and weekly dosing for first month is 31-34 days Distribution: volume of distribution is 7.1 – 8.6 (IV administration) Metabolism: Metabolized via intracellular catabolism Elimination: half-life is 22-31 days. Mechanism Of Action : Human IgG1 monoclonal antibody which selectively joins to and negate the pro inflammatory cytokine interleukin 17A (IL-17A) IL-17A is a normally appearing cytokine which is involved in normal inflammatory and immune responses and plays a key role in the patho...

XOVOLTIB 40MG DESCRIPTION : Xovoltib 40mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 40mg is a prescription drugs which is used under the guidance of medical practioners. INDICATION : Xovoltib 40mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. PRECAUTIONS : Diarrhae: mostnormal condition for people administrating this drug to have diarrhea. Certain situation this diarrhea can be serious. Severe diarrhea can cause dehydration and renal problems which can sometimes lead to death. During your treatment with Xovoltib 40mg, your doctor should also to treat diarrhea primarily. Hepatic toxicity : Xovoltib 40mg can worsen liver problems. Doctor will take blood tests to monitor the liver function before and during your tr...

XOVOLTIB 30MG Xovoltib 30mg is indicated for the first-line treatment for patients with metastatic non-small cell lung cancer(NSCLC) DESCRIPTION : Xovoltib 30mg is a targeted therapy drug It used to treat non-small cell lung cancer (NSCLC). It may also be used to treat other cancers as part of clinical trial. Xovoltib 30mg is a type of regimen called protein kinase inhibitors. Xovoltib 30mg is a prescription drugs which is used under the supervision of medical practioners. MECHANISM OF ACTION : Xovoltib 30mg stops the activating sites called tyrosine kinases of various proteins within the cell. These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. DRUG – DRUG INTERACTION : Xovoltib 30mg interaction with P-gpinducers (carbamazepine, phenytoin, phenobarbital) with Xovoltib 30mg will decrease exposure to Afatinib. Xovoltib 30mg interaction with P-gpinhibitors (cyclosporine A, ketoconazole verapamil) with Xovoltib 30mg will incre...

SCAPHO 150MG Scapho 150mg  indicated for the treatment of patients with Plaque Psoriasis .  Scapho 150mg  indicated for the treatment of patients with Psoriatic arthritis. DESCRIPTION : Scapho 150mg is a type of immuno suppressant medications which reduces the effects of a chemical substance in the body which can cause inflammation.   Scapho 150mg is needed to cure moderate to severe plaque psoriasis (raised, silvery flaking of the skin) in adults. MECHANISM OF ACTION :  Human IgG1 monoclonal antibody which selectively joins to and negate the proinflammatory cytokine interleukin 17A (IL-17A)  IL-17A is a normally appearing cytokine which is involved in normal inflammatory and immune responses and plays a key role in the pathogenesis of plaque psoriasis. PRECAUTIONS :  • Scapho may have high risk of infections; use with caution in patients with chronic infection or a history of recurrent infection. • May infuriate Crohn...

XOVOLTIB – 20MG Description : Xovoltib 20mg is a targeted therapy drug used to treat non-small cell lung cancer (NSCLC). It may also be used to treat other cancers as part of clinical trial. Xovoltib 20mg is a prescription drugs which is used under the supervision of medical practioners. Mechanism Of Action : Xovoltib 20mg stops the activating sites called tyrosine kinases of various proteins within the cell. These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. By stopping these targets, it will target the cancer will shrink. Indication : Xovoltib 20mg  is used for the first-line therapy of patients with metastatic non-small cell lung cancer(NSCLC) whose cancer have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) changes mutations as detected by an FDA-approved test. Precaution : If patients have some serious condition then avoid the drug because the conditions will worse, the conditions ...

ROZEL 60MG Rozel 60mg injection is a trade name of denosumab and which belongs to type of monoclonal antibody. This drug is classified as a “bone-modifying agent”, it works as a RANK ligand (RANKL) inhibitor. Indication of Rozel 60mg Rozel 60mg Dose is indicated for the treatment of Osteoporosis occur in and women (menopause stage) (end of menopause/ change of life), whose have severe problem of fractures increased or who failed to other medication of osteoporosis.Breast cancer in women whose taking certain treatment which make severe their risk of fractures and bone loss in men with prostate cancer. Mechanism Of Action : Denosumab is decided to target RANKL (RANK ligand), a protein which act as the main signal to help bone removal/resorption. Some of the bone loss conditions, RANKL overcome the body’s natural defense against bone eradication. Precautions : Rozel 60mg Dose may improve the negative effects of immuno-suppressants. Especially the risk for severe infecti...

XOVOLTIB – 30MG Description : Xovoltib 30mg belongs to the class of medications called protein kinase inhibitors. It may also be used to treat other cancers as part of clinical trial. Xovoltib 30mg is a prescription drugs which is used under the supervision of medical practioners. Xovoltib 30mg is a targeted therapy drug used to treat non-small cell lung cancer (NSCLC). Indication : Xovoltib 30mg is used for the first-line therapy of patients with metastatic non-small cell lung cancer(NSCLC) whose cancer have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) changes mutations as detected by an FDA-approved test. Dosage and administration : For adult the dose for metastatic non-small cell lung cancer is the usual dose is 40mg taken once per day. For child dosage ages of 0-17 years is not been studied in children. The drug should not be used age under 18 years of age For renal impairment: usual dose is 30mg taken once per day Take Xovoltib on an...

OLIMAB 60MG Olimab 60mg injection is a trade name of denosumab and which belongs to type of monoclonal antibody.This drug is classified as a “bone-modifying agent”, it works as a RANK ligand (RANKL) inhibitor. Olimab 60mg injection which attach and repairs only certain cells in the body and help to protect healthy cells from destroy. Indication of olimab : Olimab 60mg injection is indicated for the treatment of Osteoporosis occur in and women (menopause stage) (end of menopause/ change of life), whose have severe problem of fractures increased or who failed to other medication of osteoporosis. Olimab 60mg injection is indicated for the treatment of Osteoporosis occur in and women (menopause stage) (end of menopause/ change of life), whose have severe problem of fractures increased or who failed to other medication of osteoporosis. Contraindication : Olimab is contraindicated in  Hypocalcemia Pregnancy Hypersensitivity. Mechanism Of Action : Denosumab is decided ...

ROZEL 60MG Description : Rozel 60mg  belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains.   Rozel prescribed for : Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. Drug Interaction : No formal drug-drug interaction with denosumab during trials. When interacting with some anticancer drug, orthopedic drugs, vaccines will lead to risk of adverse effects can be increased. Dosage Ad...

Sprycel 20mg Description Sprycel 20mg is a prescription drug which used under the supervision of doctor. Sprycel 20mg is a potent, which contains ATP-competitive tyrosine kinase inhibitor. It is also belonging to second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with 325-fold more potency than imatinib and is also able to inhibit imatinib-resistant BCR-ABL mutants. INDICATION Sprycel 20mg the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy.Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy. MECHANISM OF ACTION Tyrosine kinases are proteins that works as chemical messengers to stimulate cancer cells to develop. Dasatinib inhibits the tyrosine kinases from sending chemical signals which tell the cells to grow. Dasatinib is a group of drugs called a protein tyrosine kinase inhibit...

Xgeva 120mg Description : Xgeva 120mg injection is a trade name of denosumab. This drug is classified as a “bone-modifying agent”, it works as a RANK ligand (RANKL) inhibitor. Xgeva 120mg injection which attack and damage only certain cells in the body and help to protect healthy cells from demolish. Indication : In adults and some adolescents with giant cell tumor of bone which cannot cured with surgery / surgery is not possible is treated with Xgeva 120mg injection .Xgeva 120mg is indicated to treat breast cancer in women whose taking certain treatment which make severe their risk of fractures and bone loss in men with prostate cancer. Xgeva 120mg injection is indicated for the treatment of osteoporosis occur in and women (menopause stage) (end of menopause/ change of life), whose risk of fractures increased or who failed to other medication of osteoporosis.  ADME Peak plasma concentration: 6.75mcg/mL Tmax : 10days Without aggregation in Xgeva pharmacokinetics...

Xovoltib 20mg   Description  :  Xovoltib 20mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 20mg is a prescription drugs which is used under the guidance of medical practioners. Indication :  Xovoltib 20mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. Mechanism :  Xovoltib 20mg blocking the activating sites called tyrosine kinases of various proteins within the cell. These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. By stopping these targets, it will target the cancer will shrink. Side Effects :  Loss of appetite, Nausea , Vomiting, Diarrhoea, Mouth sores, Acne, Itchiness, Rash, Dryskin, Nail infection.. Drug Inter...

SCAPHO-150MG DESCRIPTION  Scapho is a prescription drugs which is used under proper guidance of medical oncologist. Secukinumab belongs to monoclonal antibody which is a protein which recognises and connect to an inflammatory protein called Interleukin 17A (IL-17A). INDICATION Scapho indicated for the treatment of following condition : Plaque Psoriasis Psoriatic arthritis Ankylosing spondylitis. PHARMACOLOGICAL     Mechanism : Secukinumab consist of human IgG1 monoclonal antibody which selectively binds to IL-17A, rapidly prohibiting its pro-inflammatory effects. Secukinumab mechanism as Interleukin-17A (IL-17A) is a cornerstone cytokine (messenger protein) contains in the development of psoriasis and is found in peak concentrations in psoriasis plaques.   Precaution :  Scapho may have high risk of infections; use with caution in patients with chronic infection or a history of recurrent infection. Before to...